The physIQ accelerateTM solution monitors patients 24/7 to expedite decentralized clinical trials, evaluate drug safety, validate therapeutic efficacy and ease the path to swifter regulatory submissions with real-world patient data.  We do this by offering a robust digital platform with the perfect trifecta of:

1.      Sensors: 100% device agnostic, right biosensor for right patient, experts in signal detection, multivariate data collection, near real-time continuous RPM

2.      Analytics: 5 FDA-cleared biomarkers, AI-based insights, 40 algorithms, 30-year machine learning experience, “we learn you and detect when you’re changing”

3.      Infrastructure: medical grade, highly scalable, 2M+ hours of on-body patient data, consistent and clean data “you can use,” keeps original source data, rich data lake/trove

As a leading pioneer of patient data insights, physIQ enables clinicians and researchers to make smarter, faster, better decisions to drive healthier outcomes. PhysIQ is the only company with a medical grade, AI-powered digital platform that “learns” and continuously monitors each person’s health status against their own unique baseline to provide proactive, predictive and personalized insights from any wearable biosensor.  Near real-time physiological data, combined with advanced analytics, helps healthcare delivery and life sciences organizations to detect potentially life-threatening events sooner, deliver preventive care and bring new treatments to market faster.  

RiskVue™, comprised of over 500 hard coded algorithms based on evidence-based published gudielines developed by major medical associations, i.e., United States Preventive Services Task Force, American Heart Association, American Diabetes Association, etc., is powered by a large language model, developed with support from Harvard and Stanford professionals, and has a patent-pending for combined risk and symptom assessment and a new methodology for AI diagnosis,  

RiskVue™ has been awarded contracts by both the NCI/NIH and the NHS (UK), and is the world's most comprehensive risk and symptom assessment application based on family history, lifestyle, social determinants of health, frailty, smoking history, BMI, osteoporosis, vaccination history, preventive measure utilization, cognitive assessment, sexual activity, mental health, Medicare Annual Wellness Visit, etc.

RiskVue™ produces a differential diagnosis with an accuracy level surpassing the Mayo Clinic's own published results based on 50 real world case studies. Patient acceptance was validated and published by Stanford.

Elevate medical practice by earlier disease detection and improved diagnosis via more accurate data collection, better risk and symptom assessment, faster charting, and increased revenue by higher level E&M billing. Now, achieve better outcomes in less time for more money.

Discover SOAP, a patented and clinically validated, Epic, AthenaHealth, etc. EHR-integrated, conversational AI-powered patient and physician-facing interface for more accurate patient data collection and analysis; an unrelenting focus on improving patient outcomes and eliminating administrative burdens. 

PhysIQ products are built on decades of machine learning experience combined with leading medical insights to create full featured remote patient monitoring solution.

The AccelerateIQ solution is built on 5 FDA-cleared biomarkers, AI-based insights, 40 algorithms, 30-year machine learning experience. No other remote patient monitoring solution can match this experience.

Make EHR use considerably easier and more productive. 

Patented, patents pending, end to end clinical solution, AI and hard coded framework, experienced team, built over 9 years to be the best in class. Fastest growing application in Athena Marketplace.